Vipergen ApS is privately owned and incoporated in Copenhagen, Denmark. The company was founded in 2005 and currently has 9 employees (9 PhDs). The company is dedicated to the development and commercialization of the YoctoReactor® drug discovery platform. The YoctoReactor® technology platform is exclusively owned by Vipergen and secured by a strong patent position.
Supervisors and expertise*
Dr. Nils Hansen, CEO, Supervisory board: Preparation of DNA conjugates, DNA directed chemistry and design and characterization of DNA structures, Drug development through the Yoctoreactor technology.